To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of…
Ended Awarded Last action
- Contract number
- 75N91021F00111
- Awardee
-
Waters Technologies Corporation UEI JFT8BGF7FKV6 Part of Waters Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$0
Award facts
- Contract value 0% obligated
- $40,068.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$0 | |
| Original award | $40,069 |
About this award
The National Cancer Institute awarded a delivery order valued at $40,068.51 to Waters Technologies Corporation, a subsidiary of Waters Corporation, for administrative de-obligation of unexpended and expiring fiscal year 2021 funding in preparation for the September 30, 2026 closing of the period of availability for these funds. This firm fixed-price delivery order was issued under the General Services Administration's Multiple Award Schedule contract vehicle and was completed by March 31, 2022. No set-aside designation was applied to this award. The contract performance location was Bethesda, Maryland.
Waters Technologies Corporation is a leading global manufacturer of advanced analytical instrumentation, specializing in liquid chromatography systems, mass spectrometry instruments, and associated software and services. The company serves as a prime federal contractor across multiple civilian and defense agencies, including the National Institutes of Health, Food and Drug Administration, Environmental Protection Agency, and Department of Defense. Waters maintains significant Indefinite Delivery/Indefinite Quantity contract vehicles, including a $1 billion single-award blanket purchase agreement with the National Institutes of Health for medical and scientific instruments, software, and training in support of biomedical research, enabling federal agencies to rapidly procure specialized analytical instrumentation and comprehensive maintenance services on an expedited basis.
Description
To administratively DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552 (a), in preparation for september 30, 2026, closing of the period of availability of these fiscal year funds.
Quick answers
Who was awarded contract 75N91021F00111?
75N91021F00111 was awarded to Waters Technologies Corporation by National Cancer Institute (National Institutes of Health) on April 1, 2021.
How much is contract 75N91021F00111 worth?
The government has obligated -$0 on 75N91021F00111. Its current value, with exercised options, is $40,069.
Is contract 75N91021F00111 an order under another contract?
Yes. 75N91021F00111 is a delivery order under GS07F0559X, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N91021F00111 competed?
The extent of competition for 75N91021F00111 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award